Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Allred

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Melanoma Research|December 7, 2018
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1Matthew S Block, Wendy K Nevala, Yuan-Ping Pang, et al.
Journal of Geriatric Oncology|November 21, 2012
Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic TrialsAminah Jatoi, Jacob B Allred, Vera J Suman, et al.
American Journal of Clinical Oncology|August 8, 2012
A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338Vivek Roy, Barbara A Pockaj, Jacob B Allred, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2010
Regional immunity in melanoma: immunosuppressive changes precede nodal metastasisAaron S Mansfield, Shernan G Holtan, Travis E Grotz, et al.
Clinical Breast Cancer|January 18, 2016
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer PatientsWinston W Tan, Jacob B Allred, Alvaro Moreno-Aspitia, et al.
Cancer|November 20, 2009
Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myelomaEric W Schaefer, Shaji Kumar, Angela Dispenzieri, et al.
American Journal of Clinical Oncology|December 6, 2012
Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancerDonald W Northfelt, Jacob B Allred, Heshan Liu, et al.
Cancer Medicine|July 2, 2016
Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanomaWilliam G Rule, Jacob B Allred, Barbara A Pockaj, et al.
Clinical Neuroradiology|July 3, 2013
Prevalence of incidental narrowing of the superior segment of the internal jugular vein in patients without multiple sclerosisF E Diehn, K M Schwartz, C H Hunt, et al.
Psycho-Oncology|May 22, 2015
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)Aminah Jatoi, Hyman Muss, Jake B Allred, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Melanoma Research|December 7, 2018
A pilot clinical trial testing topical resiquimod and a xenopeptide as immune adjuvants for a melanoma vaccine targeting MART-1Matthew S Block, Wendy K Nevala, Yuan-Ping Pang, et al.
Journal of Geriatric Oncology|November 21, 2012
Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic TrialsAminah Jatoi, Jacob B Allred, Vera J Suman, et al.
American Journal of Clinical Oncology|August 8, 2012
A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338Vivek Roy, Barbara A Pockaj, Jacob B Allred, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2010
Regional immunity in melanoma: immunosuppressive changes precede nodal metastasisAaron S Mansfield, Shernan G Holtan, Travis E Grotz, et al.
Clinical Breast Cancer|January 18, 2016
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer PatientsWinston W Tan, Jacob B Allred, Alvaro Moreno-Aspitia, et al.
Cancer|November 20, 2009
Residual serum monoclonal protein predicts progression-free survival in patients with previously untreated multiple myelomaEric W Schaefer, Shaji Kumar, Angela Dispenzieri, et al.
American Journal of Clinical Oncology|December 6, 2012
Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancerDonald W Northfelt, Jacob B Allred, Heshan Liu, et al.
Cancer Medicine|July 2, 2016
Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanomaWilliam G Rule, Jacob B Allred, Barbara A Pockaj, et al.
Clinical Neuroradiology|July 3, 2013
Prevalence of incidental narrowing of the superior segment of the internal jugular vein in patients without multiple sclerosisF E Diehn, K M Schwartz, C H Hunt, et al.
Psycho-Oncology|May 22, 2015
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)Aminah Jatoi, Hyman Muss, Jake B Allred, et al.
Pageof 8